Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0ZNAID
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
SHR-A1307
|
|||||
| Synonyms |
SHR A1307; SHRA1307
Click to Show/Hide
|
|||||
| Organization |
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Clinical candidate
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Structure |
|
|||||
| Antibody Name |
Anti-EGFR mAb hR3-YTE
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
SHR152852
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
L2-MC
|
Linker Info | ||||
| Combination Type |
L2-MC-SHR152852
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.